Dosage regimen for an S1P receptor modulator or agonist

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Wallstroem, Erik

申请号：

AU2015255205

公开号：

AU2015255205A1

申请日:

2015.11.10

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

#$%^&*AU2015255205A120151126.pdf#####H:szp\Interwoven\NRPortbl\DCC\SZP\8680019 1docx-10/11/2015 ABSTRACT This invention relates to a method of treating multiple sclerosis in a mammalian patient, preferably a human, in need of such treatment, comprising administering to said human an S1 P receptor modulator or agonist according to a dosing regimen that is determined with reference to the patients blood lymphocyte count.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/